Evidence map›Paper›PMID 27433905›Full record

Trial reportAnnals of surgery2016

Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.

David N Herndon, Charles D Voigt, Karel D Capek, Paul Wurzer, Ashley Guillory, Andrea Kline, Clark R Andersen, Gordon L Klein, Ronald G Tompkins, Oscar E Suman and 3 more

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 29 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 4 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00239668 completednot on this map

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors

TypeobservationalSponsorMassachusetts General HospitalRan2000 to 2013Enrolled3,000ConditionsBurn
NCT00675714 phase2 / phase3terminatednot on this map

Assessment of the Treatment of the Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation

TypeinterventionalSponsorThe University of Texas Medical Branch, GalvestonRan2004 to 2019Enrolled1,126ConditionsBurnsArmsStable Isotope Infusion Study, Collection of blood and tissues, Radiology testing: Dual-energy X-ray absorptiometry (DEXA), ultrasound, MRI, Humatrope, Ketoconazole
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 4 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients.Journal of burn care & research : official publication of the American Burn Association
    Trial
  7. Article
  8. A review of the role of testosterone in the care of the critically ill patient.The Southern African journal of critical care : the official journal of the Critical Care Society · 2024
    Review
  9. Review
  10. Article
  11. Application of beta-blockers in burn management.Proceedings (Baylor University. Medical Center) · 2022
    Article
  12. Cutaneous Thermal Injury Modulates Blood and Skin Metabolomes Differently in a Murine Model.Journal of burn care & research : official publication of the American Burn Association · 2021
    Article
  13. Article
  14. Review
  15. Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned.Burns : journal of the International Society for Burn Injuries · 2020
    Review
  16. Review
  17. Current problems in burn hypermetabolism.Current problems in surgery · 2020
    Review
  18. Review
  19. Investigation into Possible Association of Oxandrolone and Heterotopic Ossification Following Burn Injury.Journal of burn care & research : official publication of the American Burn Association · 2019
    Article
  20. Cardiovascular Effect of Varying Interval Training Frequency in Rehabilitation of Severely Burned Children.Journal of burn care & research : official publication of the American Burn Association · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

David N Herndon*Department of Surgery †Institute for Translational Sciences, University of Texas Medical Branch ‡Shriners Hospital for Children-Galveston, Galveston, TX §Division of Plastic Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, Graz, Austria ¶Department of Orthopedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston ||Department of Surgery, Massachusetts General Hospital, Boston, MA **Sealy Center for Molecular Medicine ††Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston.
Charles D Voigt
Karel D Capek
Paul Wurzer
Ashley Guillory
Andrea Kline
Clark R Andersen
Gordon L Klein
Ronald G Tompkins
Oscar E Suman
Celeste C Finnerty
Walter J Meyer
Linda E Sousse
Shriners Hospitals for Children - Galveston · USNational Center for Advancing Translational Sciences · US

Funding

UTMB Clinical and Translational Science AwardUL1TR001439 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI URBAN, RANDALL J · 2015 to 2024
$40.0M
Project 9: The role of androgen/corticosteroid in fat, muscle and glucose metabolism of burn victimsP50GM060338 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HERNDON, DAVID N. · 2000 to 2017
$24.2M
MODULATION OF THE POSTBURN HYPERMETABOLIC RESPONSER01GM056687 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HERNDON, DAVID N. · 1998 to 2017
$9.0M
Emory University Prevention Research CenterU48DP000043 · DP · EMORY UNIVERSITY · PI GLANZ, KAREN · 2004 to 2009
$7.0M
Oxandrolone and Exercise: A potent therapy in the rehabilitation from burnsR01HD049471 · NICHD · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SUMAN-VEJAS, OSCAR E. · 2006 to 2019
$5.8M
POSTDOCTORAL TRAINING IN TRAUMA &BURNST32GM008256 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Celeste Campbell Finnerty, Oscar E. Suman-Vejas · 1990 to 2026
$4.0M
Effects of Chronic Catecholamine Exposure on Post-burn ScarringR01GM112936 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI FINNERTY, CELESTE CAMPBELL · 2015 to 2019
$1.8M
NCATS NIH HHS UL1 TR001439NCCDPHP CDC HHS U48 DP000043NICHD NIH HHS R01 HD049471NIGMS NIH HHS P50 GM060338NIGMS NIH HHS R01 GM056687NIGMS NIH HHS R01 GM112936NIGMS NIH HHS T32 GM008256
6 · The paper itself

Abstract

backgroundThe hypercatabolic response in severely burned pediatric patients is associated with increased production of catecholamines and corticosteroids, decreased formation of testosterone, and reduced strength alongside growth arrest for up to 2 years after injury. We have previously shown that, in the pediatric burned population, the administration of the testosterone analog oxandrolone improves lean body mass accretion and bone mineral content and that the administration of the β1-, β2-adrenoceptor antagonist propranolol decreases cardiac work and resting energy expenditure while increasing peripheral lean mass. Here, we determined whether the combined administration of oxandrolone and propranolol has added benefit.

methodsIn this prospective, randomized study of 612 burned children [52% ± 1% of total body surface area burned, ages 0.5-14 years (boys); ages 0.5-12 years (girls)], we compared controls to the individual administration of these drugs, and the combined administration of oxandrolone and propranolol at the same doses, for 1 year after burn. Data were recorded at discharge, 6 months, and 1 and 2 years after injury.

resultsCombined use of oxandrolone and propranolol shortened the period of growth arrest by 84 days (P = 0.0125 vs control) and increased growth rate by 1.7 cm/yr (P = 0.0024 vs control).

conclusionsCombined administration of oxandrolone and propranolol attenuates burn-induced growth arrest in pediatric burn patients. The present study is registered at clinicaltrials.gov: NCT00675714 and NCT00239668.

Indexed as

AdolescentBurnsChildChild, PreschoolDrug Therapy, CombinationFemaleGrowthGrowth DisordersHumansInfantMaleOxandrolonePropranololProspective StudiesTestosteroneOxandrolonePropranololTestosterone

Identifiers

PMID27433905
PMCPMC5167626
OpenAlexW2504310841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.